BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20457790)

  • 1. Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling.
    Martin DL; Murali-Krishna K; Tarleton RL
    Infect Immun; 2010 Jul; 78(7):3154-9. PubMed ID: 20457790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
    Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
    Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.
    Rosenberg CS; Martin DL; Tarleton RL
    J Immunol; 2010 Jul; 185(1):560-8. PubMed ID: 20530265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.
    Padilla A; Xu D; Martin D; Tarleton R
    Infect Immun; 2007 Jan; 75(1):231-5. PubMed ID: 17043105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING Signaling Drives Production of Innate Cytokines, Generation of CD8
    Vieira RS; Nascimento MS; Noronha IH; Vasconcelos JRC; Benvenuti LA; Barber GN; Câmara NOS; Kalil J; Cunha-Neto E; Almeida RR
    Front Immunol; 2021; 12():775346. PubMed ID: 35095849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
    Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
    PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.
    Dhiman M; Garg NJ
    PLoS Pathog; 2014 Dec; 10(12):e1004516. PubMed ID: 25474113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
    Martin D; Tarleton R
    Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Foxp3
    Araujo Furlan CL; Tosello Boari J; Rodriguez C; Canale FP; Fiocca Vernengo F; Boccardo S; Beccaria CG; Adoue V; Joffre O; Gruppi A; Montes CL; Acosta Rodriguez EV
    Front Immunol; 2018; 9():2555. PubMed ID: 30455700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi.
    Ersching J; Vasconcelos JR; Ferreira CP; Caetano BC; Machado AV; Bruna-Romero O; Baron MA; Ferreira LR; Cunha-Neto E; Rock KL; Gazzinelli RT; Rodrigues MM
    PLoS Pathog; 2016 Apr; 12(4):e1005593. PubMed ID: 27128676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B; Nunes M; Tarleton RL
    J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+ T Cell Responses.
    Bunkofske ME; Perumal N; White B; Strauch EM; Tarleton R
    J Immunol; 2023 Feb; 210(4):420-430. PubMed ID: 36603035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
    Chowdhury IH; Lokugamage N; Garg NJ
    Front Immunol; 2020; 11():595039. PubMed ID: 33414785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
    Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
    J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During
    Tosello Boari J; Araujo Furlan CL; Fiocca Vernengo F; Rodriguez C; Ramello MC; Amezcua Vesely MC; Gorosito Serrán M; Nuñez NG; Richer W; Piaggio E; Montes CL; Gruppi A; Acosta Rodríguez EV
    Front Immunol; 2018; 9():2347. PubMed ID: 30364284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 participates in the expansion and functional activation of CD8
    Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
    J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?
    Dos Santos Virgilio F; Pontes C; Dominguez MR; Ersching J; Rodrigues MM; Vasconcelos JR
    Mediators Inflamm; 2014; 2014():243786. PubMed ID: 25104879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.
    Martin DL; Weatherly DB; Laucella SA; Cabinian MA; Crim MT; Sullivan S; Heiges M; Craven SH; Rosenberg CS; Collins MH; Sette A; Postan M; Tarleton RL
    PLoS Pathog; 2006 Aug; 2(8):e77. PubMed ID: 16879036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.